{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T00:33:54Z","timestamp":1768696434270,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,7,24]],"date-time":"2007-07-24T00:00:00Z","timestamp":1185235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,7,24]],"date-time":"2007-07-24T00:00:00Z","timestamp":1185235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s12032-007-0047-3","type":"journal-article","created":{"date-parts":[[2007,7,23]],"date-time":"2007-07-23T15:38:03Z","timestamp":1185205083000},"page":"445-448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Systemic lupus Erythematosus and IgA multiple myeloma: a rare association?"],"prefix":"10.1007","volume":"24","author":[{"given":"J.","family":"Bila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Suvajdzic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Elezovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Colovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Boskovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,7,24]]},"reference":[{"issue":"4","key":"47_CR1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/ard.51.4.437","volume":"51","author":"T Pettersson","year":"1992","unstructured":"Pettersson T, Pukkala E, Teppo L, Friman C. Increase risk of cancer in patients with systemic lupus Erythematosus. Ann Rheum Dis 1992;51(4):437\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"47_CR2","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/art.1780390625","volume":"39","author":"M Abu-Shakra","year":"1996","unstructured":"Abu-Shakra M, Gladman DD, Urowitz MB. Malignancy in systemic lupus Erythematosus. Arthritis Rheum 1996;39(6):1050\u20134.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"47_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/art.1780400424","volume":"40","author":"L Mellemkjaer","year":"1997","unstructured":"Mellemkjaer L, et al. Non-Hodgkin\u2032s lymphomas and other cancers among a cohort of patients with systemic lupus Erythematosus. Arthritis Rheum 1997;40(4):761\u20138.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"47_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/jech.54.6.431","volume":"54","author":"P Vineis","year":"2000","unstructured":"Vineis P, et al. Haematopoietic cancer and medical history: a multicentre case control study. J Epidemiol Community Health 2000;54(6):431\u20136.","journal-title":"J Epidemiol Community Health"},{"issue":"6","key":"47_CR5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1191\/096120301678646128","volume":"10","author":"J Cibere","year":"2001","unstructured":"Cibere J, Sibley J, Haga M. Systemic lupus Erythematosus and the risk of malignancy. Lupus 2001;10(6):394\u2013400.","journal-title":"Lupus"},{"issue":"12","key":"47_CR6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1191\/096120301701548481","volume":"10","author":"Y Xu","year":"2001","unstructured":"Xu Y, Wiernik PH. Systemic lupus Erythematosus and B-cell hematologic neoplasm. Lupus 2001;10(12):841\u201350.","journal-title":"Lupus"},{"issue":"6","key":"47_CR7","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0049-0172(97)80029-7","volume":"26","author":"A Afeltra","year":"1997","unstructured":"Afeltra A, et al. Systemic lupus Erythematosus and multiple myeloma: a rare association. Semin Arthritis Rheum 1997;26(6):845\u20139.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"47_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/art.1780210215","volume":"21","author":"E Jordan","year":"1978","unstructured":"Jordan E, Burnstein SL, Calabro JJ, Henderson ES. Multiple myeloma complicating the course of seronegative systemic lupus Erythematosus. Arthritis Rheum 1978;21(2):260\u20135.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"47_CR9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2340\/0001555558527530","volume":"58","author":"M Pehamberger","year":"1978","unstructured":"Pehamberger M, Diem E, Konrad K. Systemic lupus Erythematosus with multiple myeloma. Acta Derm Venereol 1978;58(6):527\u201330.","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"47_CR10","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/art.1780290721","volume":"29","author":"E Solary","year":"1986","unstructured":"Solary E, et al. Systemic lupus Erythematosus occurring in a patient with multiple myeloma. Arthrtis Rheum 1986;29(7):933\u20134.","journal-title":"Arthrtis Rheum"},{"key":"47_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1749-6632.1971.tb13560.x","volume":"190","author":"T Isobe","year":"1971","unstructured":"Isobe T, Osserman EF. Pathologic conditions associated with plasma cell dyscrasias: a study of 806 cases. Ann N Y Acad Sci 1971;190:507\u201318.","journal-title":"Ann N Y Acad Sci"},{"key":"47_CR12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/ard.43.4.653","volume":"43","author":"RC Butler","year":"1984","unstructured":"Butler RC, Thomas SM, Thomson JM, Keat ACS. Anaplastic myeloma in systemic lupus Erythematosus. Ann Rheum Dis 1984;43:653\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"1 pt 1","key":"47_CR13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0190-9622(87)80180-9","volume":"16","author":"E Sendagorta","year":"1987","unstructured":"Sendagorta E, Matarredona J, Brieva JA, Rodriguez ML, Ledo A. Systemic lupus Erythematosus in association with smoldering multiple myeloma. J Am Acad Dermatol 1987;16(1 pt 1):135\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"47_CR14","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1080\/1042819021000029740","volume":"44","author":"G Vaiopoulos","year":"2003","unstructured":"Vaiopoulos G, Konstatopoulos K, Mantzourani M, Kaklamanis P. Multiple myeloma associated with systemic lupus Erythematosus. Leuk Lymphoma 2003;44(5):893\u20134.","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"47_CR15","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1080\/10428190410001663581","volume":"45","author":"H Urbanska-Rys","year":"2004","unstructured":"Urbanska-Rys H, et al. Multiple myeloma in a patient with systemic lupus Erythematosus, myasthenia gravis and non-familial diffuse palmoplantar keratoderma. Leuk Lymphoma 2004;45(9):1913\u20138.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"47_CR16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/096120339300200309","volume":"2","author":"S Menon","year":"1993","unstructured":"Menon S, Snaith J, Isenberg DA. The association of malignancy with SLE.: an analysis of 150 patients under long term review. Lupus 1993;2(3):177\u201381.","journal-title":"Lupus"},{"issue":"8","key":"47_CR17","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/sj.leu.2400715","volume":"11","author":"G Munzert","year":"1997","unstructured":"Munzert G, Frickhofen N, Bauditz J, Schreiber S, Herrmann F. Concomitant manifestations of systemic lupus Erythematosus and low-grade non-Hodgkin\u2019s lymphoma. Leukemia 1997;11(8):1324\u20138.","journal-title":"Leukemia"},{"issue":"6","key":"47_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1191\/096120301678646100","volume":"10","author":"R Ramsey-Goldman","year":"2001","unstructured":"Ramsey-Goldman R, Clarke A. Double trouble: are lupus and malignancy associated? Lupus 2001;10(6):388\u201391.","journal-title":"Lupus"},{"issue":"3","key":"47_CR19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/107327489700400305","volume":"4","author":"J. Valeriano","year":"1997","unstructured":"Valeriano J. Malignancy and rheumatic disease. Cancer Control 1997;4(3):236\u201344.","journal-title":"Cancer Control"},{"issue":"1","key":"47_CR20","first-page":"69","volume":"8","author":"CA Agudelo","year":"1981","unstructured":"Agudelo CA, Schumacher HR, Glick JH, Molina J. Non-Hodgkin\u2019s lymphoma in systemic lupus Erythematosus: report of 4 cases with ultrastructural studies in 2. J Rheumatol 1981;8(1):69\u201378.","journal-title":"J Rheumatol"},{"issue":"8093","key":"47_CR21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0140-6736(78)92645-4","volume":"2","author":"JA Green","year":"1978","unstructured":"Green JA, Dawson AA, Walker W. Systemic lupus Erythematosus and lymphoma. Lancet 1978;2(8093):753\u20136.","journal-title":"Lancet"},{"key":"47_CR22","first-page":"55","volume":"14 Suppl 14","author":"P Yoinou","year":"1996","unstructured":"Yoinou P, Le Corre R, Dueymes M. Autoimmune diseases and monoclonal gammopathies. Clin Exp Rheumatol 1996;14 Suppl 14:55\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"47_CR23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/art.1780270606","volume":"27","author":"L Rubin","year":"1984","unstructured":"Rubin L, Urowitz MB, Pruzanski W. Systemic lupus Erythematosus with paraproteinemia. Arthritis Rheum 1984;27(6):638\u201344.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"47_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/ard.50.5.290","volume":"50","author":"C Kelly","year":"1991","unstructured":"Kelly C, Baird G, Foster H, Hosker H, Griffiths I. Prognostic significance of paraproteinemia in rheumatoid arthritis. Ann Rheum Dis 1991;50(5):290\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"47_CR25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2141.1979.tb03677.x","volume":"41","author":"AI Schafer","year":"1979","unstructured":"Schafer AI, Miller JB. Association of IgA multiple myeloma with pre-existing disease. Br J Haematol 1979;41(1):19\u201324.","journal-title":"Br J Haematol"},{"issue":"6","key":"47_CR26","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1182\/blood.V97.6.1566","volume":"97","author":"T Facon","year":"2001","unstructured":"Facon T, et al. Chromosome 13 abnormalities identified by FISH analysis and serum beta2 microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy. Blood 2001;97(6):1566\u201371.","journal-title":"Blood"},{"issue":"4","key":"47_CR27","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1182\/blood.V98.4.1271","volume":"98","author":"R Fonseca","year":"2001","unstructured":"Fonseca R, Oken MM, Greipp RP. Eastern Cooperative Oncology Group Myeloma Group. The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significance. Blood 2001;98(4):1271\u20132.","journal-title":"Blood"},{"issue":"24","key":"47_CR28","first-page":"5640","volume":"58","author":"H Avet-Loiseau","year":"1998","unstructured":"Avet-Loiseau H, et al. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies. Cancer Res 1998;58(24):5640\u20135.","journal-title":"Cancer Res"},{"issue":"1","key":"47_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2141.2004.04867.x","volume":"125","author":"H Chang","year":"2004","unstructured":"Chang H, et al. The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant. Br J Haematol 2004;125(1):64\u20138.","journal-title":"Br J Haematol"},{"issue":"28","key":"47_CR30","doi-asserted-by":"publisher","first-page":"7069","DOI":"10.1200\/JCO.2005.17.129","volume":"23","author":"W Jaksic","year":"2005","unstructured":"Jaksic W, et al. Clinical outcomes in t(4;14) multiple myeloma: a chemotherapy-sensitive disease characterized by rapid relapse and alkylating agent resistance. J C Oncol 2005;23(28):7069\u201373.","journal-title":"J C Oncol"},{"issue":"3","key":"47_CR31","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/ng0797-260","volume":"16","author":"M Chesi","year":"1997","unstructured":"Chesi M, et al. Frequent translocation t(4;14)(p16.3;q.32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genetics 1997;16(3):260\u20134.","journal-title":"Nat Genetics"},{"issue":"10","key":"47_CR32","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1182\/blood.V90.10.4062","volume":"90","author":"R Richelda","year":"1997","unstructured":"Richelda R, et al. A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves fibroblast growth receptor 3 gene. Blood 1997;90(10):4062\u201370.","journal-title":"Blood"},{"issue":"3","key":"47_CR33","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1182\/blood.V97.3.729","volume":"97","author":"M Chesi","year":"2001","unstructured":"Chesi M, et al. Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma. Blood 2001;97(3):729\u201336.","journal-title":"Blood"},{"issue":"3","key":"47_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0049-0172(91)90009-O","volume":"21","author":"EF Remmers","year":"1991","unstructured":"Remmers EF, Sano H, Wider RL. Platelet-derived growth factors and heparin-binding (fibroblast) growth factors in the synovial tissue pathology of rheumatoid arthritis. Semin Arthritis Rheum 1991;21(3):191\u20139.","journal-title":"Semin Arthritis Rheum"},{"issue":"5A","key":"47_CR35","first-page":"977","volume":"8","author":"DT Boumpas","year":"1988","unstructured":"Boumpas DT, Eleftheriades EG, Barez S, Tsokos GC. Oncogene expression and regulation in normal lymphocytes from patients with autoimmune disorders. Anticancer Res 1988;8(5A):977\u201384.","journal-title":"Anticancer Res"},{"issue":"10","key":"47_CR36","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1182\/blood-2002-02-0608","volume":"100","author":"JB Pollett","year":"2002","unstructured":"Pollett JB, Trudel S, Stern D, Li ZH, Stewart AK. Overexpression of the myeloma associated oncogene fibroblast growth factor receptor 3 confers dexamethasone resistance. Blood 2002;100(10):3819\u201321.","journal-title":"Blood"},{"issue":"1\u20132","key":"47_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3109\/10428199409114152","volume":"16","author":"RD Brown","year":"1994","unstructured":"Brown RD, Pope B, Luo XF, Gibson J, Joshua D. The oncoprotein phenotype of plasma cells from patients with multiple myeloma. Leuk Lymphoma 1994;16(1\u20132):147\u201356.","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"47_CR38","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1182\/blood-2002-04-1190","volume":"100","author":"T Standal","year":"2002","unstructured":"Standal T, et al. Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells. Blood 2002;100(8):3002\u20137.","journal-title":"Blood"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-007-0047-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-007-0047-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-007-0047-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-007-0047-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T00:56:33Z","timestamp":1708131393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-007-0047-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,24]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["47"],"URL":"https:\/\/doi.org\/10.1007\/s12032-007-0047-3","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,24]]},"assertion":[{"value":"30 March 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}